Beraud Jill

CIK 00015200614 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001520061

Recent Transactions

50 trades

Award
LEVI STRAUSS & CO$LEVI
Class B Common Stock
2026-02-25+89→ 14,285 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2026-02-25+75→ 172,776 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2025-11-04+85→ 172,701 total
Award
LEVI STRAUSS & CO$LEVI
Class B Common Stock
2025-11-04+101→ 14,196 total
Award
LEVI STRAUSS & CO$LEVI
Class B Common Stock
2025-08-08+97→ 14,095 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2025-08-08+82→ 172,616 total
Award
LEVI STRAUSS & CO$LEVI
Class B Common Stock
2025-05-09+104→ 13,998 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2025-05-09+88→ 172,534 total
Conversion
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2025-04-23+108,679→ 160,756 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2025-04-23+11,690→ 172,446 total
Conversion
LEVI STRAUSS & CO$LEVI
Class B Common Stock
2025-04-23−108,679→ 13,894 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2025-02-28+56→ 52,077 total
Award
LEVI STRAUSS & CO$LEVI
Class B Common Stock
2025-02-28+99→ 122,573 total
Disposition to Issuer
Revance Therapeutics, Inc.
Common Stock
2025-02-06−15,000→ 0 total
Disposition from Tender
Revance Therapeutics, Inc.
Common Stock
2025-02-04$3.65/sh−28,606→ 15,000 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2024-11-14+60→ 52,021 total
Award
LEVI STRAUSS & CO$LEVI
Class B Common Stock
2024-11-14+106→ 122,474 total
Award
LEVI STRAUSS & CO$LEVI
Class B Common Stock
2024-08-20+93→ 122,368 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2024-08-20+52→ 51,961 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2024-05-23+42→ 51,909 total
Award
LEVI STRAUSS & CO$LEVI
Class B Common Stock
2024-05-23+74→ 122,275 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2024-05-01+23,458→ 23,458 total
Award
Revance Therapeutics, Inc.
Common Stock
2024-05-01+15,000→ 43,606 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2024-04-24+7,642→ 51,867 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2024-02-23+69→ 44,225 total
Award
LEVI STRAUSS & CO$LEVI
Class B Common Stock
2024-02-23+88→ 122,201 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2023-11-09+87→ 44,156 total
Award
LEVI STRAUSS & CO$LEVI
Class B Common Stock
2023-11-09+112→ 122,113 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2023-08-17+88→ 44,069 total
Award
LEVI STRAUSS & CO$LEVI
Class B Common Stock
2023-08-17+113→ 122,001 total
Award
LEVI STRAUSS & CO$LEVI
Class B Common Stock
2023-05-18+117→ 121,888 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2023-05-18+129→ 43,981 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2023-05-03+5,915→ 5,915 total
Award
Revance Therapeutics, Inc.
Common Stock
2023-05-03+3,534→ 28,606 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2023-04-19+10,251→ 43,852 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2023-02-23+87→ 77,707 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2023-02-23+81→ 77,962 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2022-11-21+190→ 77,794 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2022-08-17+152→ 77,604 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2022-05-24+222→ 77,452 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2022-05-04+10,756→ 10,756 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2022-05-04+11,343→ 11,343 total
Award
Revance Therapeutics, Inc.
Common Stock
2022-05-04+6,059→ 25,072 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2022-04-20+7,812→ 77,230 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2022-02-24+129→ 69,418 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2021-11-17+81→ 69,289 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2021-08-18+94→ 69,208 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2021-07-15+5,455→ 69,114 total
Award
LEVI STRAUSS & CO$LEVI
Class A Common Stock
2021-05-25+72→ 63,659 total
Award
Revance Therapeutics, Inc.
Stock Option (Right to buy)
2021-05-05+7,551→ 7,551 total

Companies

Recent Filings

Address

C/O LEVI STRAUSS & CO. 1155 BATTERY STREET

SAN FRANCISCO, CA, 94111

View on SEC.gov